Insider Ledger
HRMY insider buying and SEC filings, explained
Harmony Biosciences Holdings, Inc. · CIK 1802665
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Company profile
- Exchanges
- Nasdaq
- Industry (SIC)
- Pharmaceutical Preparations
- State of incorporation
- DE
- Fiscal year end
- Dec 31
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$0
Planned sales (10b5-1)
$6.0M
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Sep 16–18, 2026 | Planned (10b5-1) | Kumar Budur (Chief Medical Officer) sold 38,452 shares between Sep 16 and Sep 18 at about $43.05 ($1.7M), marked as a 10b5-1 plan trade. Holdings down 75% to 13,115 shares. | SEC filing Filed Sep 18, 2026 |
| Sep 4–8, 2026 | Planned (10b5-1) | Kumar Budur (Chief Medical Officer) sold 33,954 shares between Sep 4 and Sep 8 at about $42.80 ($1.5M), marked as a 10b5-1 plan trade. Holdings down 72% to 13,115 shares. | SEC filing Filed Sep 9, 2026 |
| Jan 26, 2026 | Planned (10b5-1) | Sandip Kapadia (CFO) sold 3,746 shares at about $37.15 ($139K), marked as a 10b5-1 plan trade. Holdings down 13% to 24,521 shares. | SEC filing Filed Jan 28, 2026 |
| Jan 15, 2026 | Planned (10b5-1) | Sandip Kapadia (CFO) sold 20,961 shares at about $35.92 ($753K), marked as a 10b5-1 plan trade. Holdings down 100% to 0 shares. | SEC filing Filed Jan 20, 2026 |
| Dec 12, 2025 | Planned (10b5-1) | Jeffrey M. Dayno (CEO and Director) sold 25,933 shares at about $40.11 ($1.0M), marked as a 10b5-1 plan trade. Holdings down 100% to 0 shares. | SEC filing Filed Dec 17, 2025 |
| Dec 5, 2025 | Planned (10b5-1) | Sandip Kapadia (CFO) sold 20,000 shares at about $39.54 ($791K), marked as a 10b5-1 plan trade. Holdings down 100% to 0 shares. | SEC filing Filed Dec 9, 2025 |
| Nov 21, 2025 | Planned (10b5-1) | Sandip Kapadia (CFO) sold 3,427 shares at $35.00 ($120K), marked as a 10b5-1 plan trade. Holdings down 100% to 0 shares. | SEC filing Filed Nov 25, 2025 |
20 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
| Filed | Items | Tag | Source |
|---|---|---|---|
| Oct 30, 2026, 4:15 PM ET 8-K/A | Executive or director change (Item 5.02) | Amendment | SEC filing |
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow HRMY in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.